| 4 | Statement of changes in beneficial owner... | Ligand Pharmaceuticals Inc | Dorica De La Fuente, Inc. Dba Financial Intelligence /fa | 03/31/2026 | |
| 4 | Statement of changes in beneficial owner... | Lamattina John L | | 03/31/2026 | |
| 4 | Statement of changes in beneficial owner... | Ligand Pharmaceuticals Inc | Dorica De La Fuente, Inc. Dba Financial Intelligence /fa | 11/12/2025 | |
| 4 | Statement of changes in beneficial owner... | Lamattina John L | Dorica De La Fuente, Inc. Dba Financial Intelligence /fa | 11/12/2025 | |
| 144 | Filing for proposed sale of securities u... | Ligand Pharmaceuticals Inc | Morgan Stanley Smith Barney Llc Executive Services /fa | 11/07/2025 | |
| 144 | Filing for proposed sale of securities u... | Lamattina John L | Morgan Stanley Smith Barney Llc Executive Services /fa | 11/07/2025 | |
| 4 | Statement of changes in beneficial owner... | Ligand Pharmaceuticals Inc | Dorica De La Fuente, Inc. Dba Financial Intelligence /fa | 06/10/2025 | |
| 4 | Statement of changes in beneficial owner... | Lamattina John L | Dorica De La Fuente, Inc. Dba Financial Intelligence /fa | 06/10/2025 | |
| 4 | Statement of changes in beneficial owner... | Ligand Pharmaceuticals Inc | Financial Intelligence, Llc /fa | 12/02/2024 | |
| 4 | Statement of changes in beneficial owner... | Lamattina John L | Financial Intelligence, Llc /fa | 12/02/2024 | |
| Load More |
SEC Filing Data
